AI-powered platform to predict patient safety and efficacy profiles, unlocking precision-driven oncology development BostonGene, the developer of the leading AI foundation model for tumor and immune ...
Rhapsody version 7.1 model-driven development (MDD) tool is more tightly aligned with the Object Management Group’s Systems Modeling Language 1.0 (SysML) and offers greater support for Agile ...
WALTHAM, Mass., January 06, 2026--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results